---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-08T20:27:45.635580'
end_time: '2026-02-08T20:32:34.524114'
duration_seconds: 288.89
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: RGS20
  gene_symbol: RGS20
  uniprot_accession: O76081
  protein_description: 'RecName: Full=Regulator of G-protein signaling 20; Short=RGS20;
    AltName: Full=Gz-selective GTPase-activating protein; Short=G(z)GAP; Short=Gz-GAP;
    AltName: Full=Regulator of G-protein signaling Z1; AltName: Full=Regulator of
    Gz-selective protein signaling 1;'
  gene_info: Name=RGS20; Synonyms=RGSZ1, ZGAP1;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: RGS. (IPR016137); RGS_sf. (IPR036305); RGS_subdomain_2. (IPR044926);
    RGS (PF00615)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 16
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O76081
- **Protein Description:** RecName: Full=Regulator of G-protein signaling 20; Short=RGS20; AltName: Full=Gz-selective GTPase-activating protein; Short=G(z)GAP; Short=Gz-GAP; AltName: Full=Regulator of G-protein signaling Z1; AltName: Full=Regulator of Gz-selective protein signaling 1;
- **Gene Information:** Name=RGS20; Synonyms=RGSZ1, ZGAP1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** RGS. (IPR016137); RGS_sf. (IPR036305); RGS_subdomain_2. (IPR044926); RGS (PF00615)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RGS20" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RGS20' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RGS20** (gene ID: RGS20, UniProt: O76081) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O76081
- **Protein Description:** RecName: Full=Regulator of G-protein signaling 20; Short=RGS20; AltName: Full=Gz-selective GTPase-activating protein; Short=G(z)GAP; Short=Gz-GAP; AltName: Full=Regulator of G-protein signaling Z1; AltName: Full=Regulator of Gz-selective protein signaling 1;
- **Gene Information:** Name=RGS20; Synonyms=RGSZ1, ZGAP1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** RGS. (IPR016137); RGS_sf. (IPR036305); RGS_subdomain_2. (IPR044926); RGS (PF00615)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RGS20" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RGS20' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RGS20** (gene ID: RGS20, UniProt: O76081) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: Human RGS20 (UniProt O76081)

Verification of Target Identity and Scope
- Identity/synonyms: Regulator of G-protein signaling 20 (RGS20), also known as RGSZ1/ZGAP1, is a member of the RZ (RGSZ) subfamily originally identified for selective activity toward Gαz; these names and properties are consistent with the UniProt description provided (O76081) (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Organism: Evidence and functional studies summarized here pertain to Homo sapiens, aligning with the requested organism (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Domains/family: RGS20 contains the canonical ~120 aa RGS (RGS-box) domain and an N‑terminal cysteine-rich region typical of the RZ subfamily, consistent with the domain annotations listed (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

1) Key Concepts and Definitions with Current Understanding
- Core biochemical function: RGS20 is a GTPase-activating protein (GAP) for heterotrimeric Gα subunits, accelerating GTP hydrolysis to terminate GPCR signaling. It exhibits strong biochemical specificity for Gαz and binds/acts on Gαi1 and Gαi3, with little to no activity toward Gαi2 or Gαs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Subfamily classification: RGS20 belongs to the RZ (RGSZ) subfamily together with RGS17 and RGS19, specialized for modulation of Gi/z-coupled GPCR pathways (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Structural features and PTMs: RGS20 has a C‑terminal RGS-box mediating GAP activity and an N‑terminal cysteine-rich segment implicated in palmitoylation and membrane association; protein–protein interactions with PKCI‑1 suggest phosphorylation-linked regulation of GAP function (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- Subcellular localization: RGS20 is detected in cytosolic and nuclear pools and can associate with membranes via its N‑terminus; stimulus-dependent relocalization (e.g., to Golgi in NGF-treated cells) has been observed (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- GPCR pathway roles: Functional studies and syntheses indicate RGS20 modulates μ‑opioid receptor signaling and directly binds the MT1 melatonin receptor (interaction mapped to MT1’s third intracellular loop), illustrating selective receptor engagement within Gi/z-regulated pathways (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

2) Recent Developments and Latest Research (emphasis 2023–2024)
- Cancer signaling mechanism (2024): In non-small cell lung cancer (NSCLC), RGS20 is upregulated and promotes proliferation by activating autophagy through inhibition of PKA–Hippo signaling, decreasing YAP phosphorylation and promoting YAP nuclear translocation. Hippo inhibitor GA‑017 rescues proliferation in RGS20 knockdown cells, while the GPCR/adenylyl cyclase activator forskolin increases YAP phosphorylation and reverses RGS20-driven phenotypes; xenograft models confirm enhanced tumorigenicity upon RGS20 overexpression (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- Pan-cancer/solid tumors (2023 review): A comprehensive review of RGS family roles in solid tumors highlights RGS20 as frequently upregulated (breast, bladder, hepatocellular carcinoma, melanoma, oral cancer) and linked to proliferation, invasion, metastasis, and poor prognosis, supporting biomarker potential and oncogenic functions (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7) (yang2023functionandregulation pages 6-8).

3) Current Applications and Real-world Implementations
- Biomarker potential in oncology: Analyses in HCC and pan-cancer cohorts found RGS20 markedly upregulated in tumors vs. adjacent normal, associated with clinical parameters (e.g., alpha-fetoprotein, tumor grade) and survival in multiple cancers, suggesting prognostic utility. These findings use TCGA and GEO data with established statistical pipelines (Biology, Aug 2022; https://doi.org/10.3390/biology11081174) (wang2022regulatorofg pages 2-4).
- Therapeutic targeting rationale: The NSCLC study provides mechanistic support for targeting RGS20 or its downstream cAMP/PKA–Hippo/YAP axis to constrain tumor growth and autophagy-mediated survival, indicating a translational avenue for drug discovery or combination strategies that modulate GPCR–G protein signaling nodes (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).

4) Expert Opinions and Analysis from Authoritative Sources
- Mechanistic synthesis in oncology: Review-level synthesis argues that dysregulated RGS proteins, including RGS20, are integral to cancer cell signaling plasticity and may serve as context-dependent biomarkers and targets; for RGS20, convergent evidence across tumor types supports a pro-tumor role when overexpressed (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7) (yang2023functionandregulation pages 6-8).
- Foundational biochemical context: Detailed biochemical and structural mapping from thesis work collating primary experiments underscores RGS20’s selective GAP activity toward Gαz and interactions that regulate its localization and GAP efficacy (e.g., PKCI‑1), supporting targeted hypotheses in diseases driven by Gi/z-coupled GPCRs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).

5) Relevant Statistics and Data from Recent Studies
- NSCLC (2024): Tissue microarrays (126 paired adenocarcinoma and 75 paired squamous samples) showed higher RGS20 expression correlating with poorer 5‑year survival; functional assays and xenografts validated proliferative and autophagy phenotypes via PKA–Hippo/YAP modulation. Although exact hazard ratios are not reported in the excerpt, the study provides experimental confirmation of mechanism and in vivo tumor growth enhancement (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- HCC and pan-cancer (2022): Differential expression in TCGA LIHC (374 tumor vs 50 normal) and GEO GSE76427 (115 tumor vs 52 normal) showed marked RGS20 upregulation; survival associations (Cox regression, Kaplan–Meier) and pathway correlations (GSEA) support prognostic relevance and links to oncogenic lincRNAs, with stated significance thresholds (e.g., p < 0.05; FDR < 0.25 for GSEA). Specific hazard ratios are provided in the original article but are not present in the excerpt (Biology, Aug 2022; https://doi.org/10.3390/biology11081174) (wang2022regulatorofg pages 2-4).

Functional Role, Pathways, and Localization (Focused Narrative)
- Primary role and substrate specificity: RGS20 accelerates GTP hydrolysis on Gαz, attenuating signaling from Gi/z-coupled GPCRs; it can act on Gαi1/i3 but not Gαi2 or Gαs. This specificity underlies its modulatory effects in neuronal and other contexts where Gαz pathways are prominent (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Pathway integrations: In NSCLC, RGS20 intersects with cAMP/PKA–Hippo/YAP, consistent with a model in which altered Gi/z signaling impacts PKA activity and YAP phosphorylation/nuclear shuttling to control autophagy and proliferation (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- Receptor-level selectivity and GPCRs: RGS20’s direct binding to the MT1 melatonin receptor (but not MT2) exemplifies GPCR selectivity beyond its Gα preferences; prior functional work links it to μ‑opioid receptor signaling, aligning with its Gαz specialization (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- Subcellular site of action: Membrane association via N‑terminal cysteines and palmitoylation positions RGS20 to engage active Gα subunits at the plasma membrane; however, cytosolic/nuclear pools and stimulus-dependent trafficking indicate broader cellular dynamics that may modulate access to signaling complexes (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

Interaction Partners and Regulation
- Protein interactions: Reported interactors include PKCI‑1 (enhancing GAP activity; phosphorylation-linked), SCG10 (counteracting microtubule disassembly), and HOXA1 (transcription factor), pointing to cross-talk between GPCR signaling, cytoskeletal control, and transcriptional programs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32, leung2017theroleof pages 24-28).
- Post-translational regulation: Palmitoylation at the N‑terminus and phosphorylation within the cysteine-rich region likely control membrane targeting and activity; PKC-dependent modifications of Gαz can also influence the efficacy of RGS20 GAP activity, modulating pathway termination (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 24-28, leung2017theroleof pages 28-32).

Expression and Disease Associations
- Tissue expression: Foundational studies indicate brain-enriched expression, consistent with roles in neuronal GPCR pathways; disease contexts reveal RGS20 overexpression across multiple tumors (e.g., HCC, NSCLC, breast, melanoma, bladder), often associated with poor prognosis or aggressive phenotypes (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7; Biology, Aug 2022; https://doi.org/10.3390/biology11081174; Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (yang2023functionandregulation pages 6-8, wang2022regulatorofg pages 2-4, ding2024rgs20promotesnonsmall pages 1-2).

Limitations and Notes
- Antibody specificity caveat: Some earlier IHC studies used antibodies against conserved RGS-box sequences, risking cross-reactivity among RGS family members; studies drawing prognostic conclusions should be evaluated with this in mind (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 24-28).
- Data needs: While multiple studies show upregulation and prognostic associations, precise hazard ratios and effect sizes should be extracted from full texts/tables for clinical deployment; mechanistic generalization beyond NSCLC will require additional primary studies in other tumor types (ding2024rgs20promotesnonsmall pages 1-2, wang2022regulatorofg pages 2-4).

Embedded summary table of key facts and sources
| Aspect | Key Finding | Best Evidence | Source URL | Publication date (Month YYYY) |
|---|---|---:|---|---:|
| Identity / Synonyms | Human RGS20 (Regulator of G-protein signaling 20), also reported as RGSZ1 / ZGAP1; identified as the Gz-selective GAP family member. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Protein family / Subfamily | Member of the RZ (RGSZ) subfamily (includes RGS17, RGS19, RGS20), a small RGS group specialized in Gαz regulation. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Domains & PTMs | Contains a ~120 aa C-terminal RGS (RGS-box) domain and a cysteine-rich N-terminal region; N-terminal palmitoylation and PKC-linked phosphorylation reported, mediating membrane association. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Biochemical function & Gα specificity | Acts as a GTPase-activating protein (GAP) that accelerates GTP hydrolysis on Gα subunits; shows strong activity/binding for Gαz and measurable activity with Gαi1/Gαi3, but not Gαi2 or Gαs — thus terminates Gi/z-mediated GPCR signaling. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| GPCR pathway roles (opioid, cannabinoid, serotonin, melatonin) | Modulates μ-opioid receptor signaling (alters opioid responses) and directly binds MT1 melatonin receptor (3rd intracellular loop); review-level data implicate roles across GPCRs relevant to serotonin/cannabinoid pathways. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Subcellular localization | Reported cytosolic and nuclear pools as well as membrane-associated localization via N-terminal cysteines; stimulus-dependent relocalization (e.g., Golgi translocation in NGF-treated cells) has been observed. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Interaction partners | Validated interactions include PKCI-1 (regulatory complex), SCG10 (neuronal cytoskeleton regulator), and HOXA1 (transcription factor); databases list many additional candidates (≈95 BioGRID entries). | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Tissue expression | Baseline studies report brain-enriched expression, but recent analyses and reviews report RGS20 upregulation across multiple solid tumors (e.g., HCC, lung, breast, melanoma, bladder), indicating context-dependent expression changes in disease. | (yang2023functionandregulation pages 6-8) | https://doi.org/10.1186/s12964-023-01334-7 | Nov 2023 |
| Disease associations & mechanisms | Recent primary work (NSCLC, 2024) shows RGS20 is upregulated and promotes proliferation via autophagy by inhibiting PKA–Hippo signaling and promoting YAP nuclear translocation; other studies report RGS20 upregulation in HCC and associations with oncogenic lincRNAs and worse prognosis. | (ding2024rgs20promotesnonsmall pages 1-2) | https://doi.org/10.1186/s12935-024-03282-9 | Mar 2024 |


*Table: Table summarizing core properties, biochemical specificity, localization, interactions, expression and recent disease links for human RGS20 with primary evidence and source URLs.*

References (with URLs and publication dates)
- Ding X et al. RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway. Cancer Cell International. Mar 2024. URL: https://doi.org/10.1186/s12935-024-03282-9 (ding2024rgs20promotesnonsmall pages 1-2).
- Yang C et al. Function and regulation of RGS family members in solid tumours: a comprehensive review. Cell Communication and Signaling. Nov 2023. URL: https://doi.org/10.1186/s12964-023-01334-7 (yang2023functionandregulation pages 6-8).
- Leung MMH. The role of RGS20 in tumorigenesis and angiogenesis. PhD Thesis. 2017. URL: https://doi.org/10.14711/thesis-991012564767403412 (leung2017theroleof pages 24-28, leung2017theroleof pages 20-24, leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Wang Y et al. Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma. Biology. Aug 2022. URL: https://doi.org/10.3390/biology11081174 (wang2022regulatorofg pages 2-4).

References

1. (leung2017theroleof pages 16-20): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

2. (leung2017theroleof pages 28-32): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

3. (ding2024rgs20promotesnonsmall pages 1-2): Xiaoyan Ding, Xiaoxia Li, Yanxia Jiang, Yujun Li, Hong Li, Lipeng Shang, Guilin Feng, Huhu Zhang, Ziyuan Xu, Lina Yang, Bing Li, and Robert Chunhua Zhao. Rgs20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the pka-hippo signaling pathway. Cancer Cell International, Mar 2024. URL: https://doi.org/10.1186/s12935-024-03282-9, doi:10.1186/s12935-024-03282-9. This article has 12 citations and is from a peer-reviewed journal.

4. (yang2023functionandregulation pages 6-8): Chenglong Yang, Xiaoyuan Zhang, Xiaowen Yang, Fuming Lian, Zongrun Sun, Yong-Kang Huang, and Wenzhi Shen. Function and regulation of rgs family members in solid tumours: a comprehensive review. Cell Communication and Signaling : CCS, Nov 2023. URL: https://doi.org/10.1186/s12964-023-01334-7, doi:10.1186/s12964-023-01334-7. This article has 6 citations.

5. (wang2022regulatorofg pages 2-4): Yulu Wang, Maria F. Setiawan, Hongde Liu, Tikam Chand Dakal, Hongjia Liu, Fangfang Ge, Oliver Rudan, Peng Chen, Chunxia Zhao, Maria A. Gonzalez-Carmona, Miroslaw T. Kornek, Christian P. Strassburg, Matthias Schmid, Jarek Maciaczyk, Amit Sharma, and Ingo G. H. Schmidt-Wolf. Regulator of g protein signaling 20 correlates with long intergenic non-coding rna (lincrnas) harboring oncogenic potential and is markedly upregulated in hepatocellular carcinoma. Biology, 11:1174, Aug 2022. URL: https://doi.org/10.3390/biology11081174, doi:10.3390/biology11081174. This article has 13 citations and is from a poor quality or predatory journal.

6. (leung2017theroleof pages 24-28): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

7. (leung2017theroleof pages 20-24): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

## Citations

1. leung2017theroleof pages 28-32
2. leung2017theroleof pages 16-20
3. yang2023functionandregulation pages 6-8
4. wang2022regulatorofg pages 2-4
5. leung2017theroleof pages 24-28
6. leung2017theroleof pages 20-24
7. https://doi.org/10.14711/thesis-991012564767403412,
8. https://doi.org/10.1186/s12935-024-03282-9
9. https://doi.org/10.1186/s12964-023-01334-7
10. https://doi.org/10.3390/biology11081174
11. https://doi.org/10.1186/s12964-023-01334-7;
12. https://doi.org/10.3390/biology11081174;
13. https://doi.org/10.14711/thesis-991012564767403412
14. https://doi.org/10.1186/s12935-024-03282-9,
15. https://doi.org/10.1186/s12964-023-01334-7,
16. https://doi.org/10.3390/biology11081174,